| Sep 26 |
Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference
|
| Sep 25 |
Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
|
| Sep 25 |
Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?
|
| Sep 22 |
The Best Biotech Stock to Invest $1,000 in Right Now
|
| Sep 21 |
3 Dirt Cheap Stocks to Buy Right Now
|
| Sep 19 |
The best biotech plays outside the GLP-1 weight-loss market
|
| Sep 18 |
Top High Growth Tech Stocks to Watch in September 2024
|
| Sep 18 |
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
|
| Sep 17 |
Vertex Pharmaceuticals Incorporated (VRTX) Management presents at Cantor Global Healthcare Conference (Transcript)
|
| Sep 16 |
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
|
